Research Articles
CRISPR-Cas9: Revolutionizing Our Fight Against Cancer
Explore how CRISPR-Cas9 gene editing technology is transforming cancer research and treatment through precision genetic engineering.
CRISPR and Cancer: Rewriting the Code of Life to Fight Disease
Explore how CRISPR genome editing is revolutionizing cancer research and therapy, from CAR-T cell engineering to in vivo gene editing approaches.
CRISPR's Diagnostic Leap: How a Gene-Editing Tool Revolutionized COVID-19 Testing
Explore how CRISPR technology transformed COVID-19 testing with rapid, accurate diagnostics that bridge the gap between lab accuracy and point-of-care convenience.
CRISPR: The Bacterial Superpower Revolutionizing Our Genetic Future
Explore the revolutionary CRISPR-Cas system, a groundbreaking gene-editing technology transforming medicine, agriculture, and scientific research.
By 2020, The Genetic Scissors Had Arrived: Rewriting the Code of Life
Explore how CRISPR-Cas9, the revolutionary genetic scissors, transformed biology and medicine by 2020, earning a Nobel Prize and opening a new era of genetic engineering.
The CRISPR Architect: How Lei Qi Is Rewriting the Code of Life
Explore Lei Qi's groundbreaking CRISPR innovations that go beyond gene editing to precisely control genetic expression with revolutionary applications in medicine and biology.
The CRISPR Scalpel: Rewriting Cancer's Genetic Code
Explore how CRISPR/Cas9 gene editing is revolutionizing cancer treatment through precision genetic modifications, immune cell engineering, and targeted therapies.
Beyond Healing: The Blurring Line Between Therapy and Enhancement in CRISPR Gene Editing
Exploring the ethical frontier of CRISPR gene editing as it challenges the traditional distinction between therapy and human enhancement.
Beyond the Gene: Mapping the Genome's Epigenetic Switches with CRISPR Scissors
Exploring CRISPR-based epigenome editing tools that enable systematic annotation of epigenetic function across the entire genome.
The Silent Gene Awakens: CRISPR's Quest to Reactivate Fetal Hemoglobin
Exploring how CRISPR gene editing is being used to reactivate fetal hemoglobin as a potential cure for sickle cell disease and beta-thalassemia.